Background The WHO established targets for 2030 to globally reduce new viral hepatitis B
and C infections by 90% and deaths by 65% and recommends searching for coinfections …

With this study, the authors hope to alert clinicians regarding the presence of human T-cell
lymphotropic virus type 1 and 2 (HTLV-1/-2) infections in patients with viral hepatitis B and C …

INTRODUCTION Human retroviruses and the hepatitis B and C viruses (HBV and HCV,
respectively) share routes of transmission; thus, coinfections occur and could alter …

Both Human T-lymphotropic virus type 1 (HTLV-1) and hepatitis C virus (HCV) are endemic
in Brazil. In Salvador, the capital of the state of Bahia, 2% and 1.5% of the general …

INTRODUCTION: Human T-lymphotropic virus types 1/2 (HTLV-1/2) are distributed
worldwide and are endemic in specific regions. METHODS: Serological evaluation of the …

Hepatitis C virus (HCV) and human T-cell lymphotropic virus type 1 (HTLV-1) share routes of
transmission and some individuals have dual infection. Although some studies point to a …

During the 1990s, high prevalences of HIV/human T lymphotropic virus type 1 (HTLV-1) and
HIV/human T lymphotropic virus type 2 (HTLV-2) coinfections were detected in São Paulo …

Background Hepatitis B virus (HBV) and hepatitis C virus (HCV) are a common cause of
complications in liver disease and immunological impairment among human …

Background The human retroviruses HIV-1 and HTLV-1 share the routes of infection with
hepatitis viruses B and C. Co-infection by these agents are a common event, but we have …

Hepatitis C virus (HCV) and human T‐lymphotropic virus type 1 (HTLV‐1) coinfection occurs
in many regions. However, few studies have focused on the natural history of HCV‐induced …